Anti‐Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori Status
Helicobacter · 2025
DOI: 10.1111/hel.70093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helicobacter, 2025. Verfasst von Harindra Jayasekara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Stomach Neoplasms, Helicobacter Infections, Helicobacter pylori, Parietal Cells, Gastric. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Wellcome Trust, National Health and Medical Research Council, Intramural Research Program from the US National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Background
Autoimmune gastritis poses a risk for stomach cancer. However, its role relative to Helicobacter pylori ‐associated gastritis is uncertain. We assessed whether the associations between anti‐parietal cell antibody (APCA) seropositivity and the risk of stomach cancer and its anatomical subtypes were modified by H. pylori infection. Materials and Methods A total of 244 incident gastric adenocarcinoma cases were identified from the Melbourne Collaborative Cohort Study ( N = 41,513) and matched with 448 cancer‐free controls using incidence density sampling with age as the time scale, matching on sex, year of birth, and country of birth. IgG antibodies against parietal cells and H. pylori were analyzed using commercially available ELISA kits. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression.
Results
Seropositivity for APCA was 21% for controls and 24% for cases (28% cardia, 23% non‐cardia), while seropositivity for H. pylori was 62% for controls and 76% for cases (55% cardia, 81% non‐cardia). The following ORs were observed for total, cardia, and non‐cardia cancers in relation to APCA seropositivity: 1.21 (95% CI: 0.84–1.76), 1.99 (0.84–4.73), and 1.09 (0.71–1.66), respectively. Stronger associations were observed for cardia cancer in H. pylori ‐seropositive individuals (ORs, 3.60 [95% CI: 1.07–12.12] vs. 0.93 [0.24–3.57] for H. pylori ‐seronegative individuals; p interaction = 0.15) and for non‐cardia cancer in H. pylori ‐seronegative individuals (ORs, 2.56 [1.02–6.40] vs. 0.93 [0.56–1.54] for H. pylori ‐seropositive individuals; p interaction = 0.06).
Conclusions
Our findings suggest a more complex association between autoimmune gastritis and the risk of stomach cancer. They also highlight the importance of early detection of autoimmune gastritis in stomach cancer prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Victoria, Australia.
- School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
- School of Public Health, the University of Queensland, Queensland, Australia.
- Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, USA.
ORCID-Profile: Harindra Jayasekara
Förderung
- Wellcome Trust
- National Health and Medical Research Council
- Intramural Research Program from the US National Cancer Institute, National Institutes of Health
- Cancer Council Victoria
- VicHealth
Zitieren
APA
Jayasekara, H., Bassett, J. K., Tang, H. H., Peng, Y., Tsimiklis, H., O'Reilly, R. L., Lynch, B. M., MacInnis, R. J., Giles, G. G., Southey, M. C., Milne, R. L., & Camargo, M. C. (2025). Anti‐Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori Status. Helicobacter. https://doi.org/10.1111/hel.70093
Vancouver
Jayasekara H, Bassett JK, Tang HH, Peng Y, Tsimiklis H, O'Reilly RL, et al. Anti‐Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori Status. Helicobacter. 2025. doi:10.1111/hel.70093
BibTeX
@article{Jayasekara2025,
author = {Jayasekara, Harindra and Bassett, Julie K and Tang, Howard Ho-Fung and Peng, Yang and Tsimiklis, Helen and O'Reilly, Robert L and Lynch, Brigid M and MacInnis, Robert J and Giles, Graham G and Southey, Melissa C and Milne, Roger L and Camargo, M Constanza},
title = {Anti‐Parietal Cell Antibodies Show Differential Associations With Stomach Cancer by Site and Helicobacter pylori Status},
journal = {Helicobacter},
year = {2025},
doi = {10.1111/hel.70093}
}
EUVIMED